Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Clinical trial NCT03889756 · TERMINATED

Trial details

NCT number: NCT03889756
Sponsor: Yale University
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2019-07-17
Primary completion: 2019-12-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.